Merck & Co., Inc. (MRK)
146.94
-3.42
(-2.27%)
USD |
NYSE |
Nov 05, 16:00
145.00
-1.94
(-1.32%)
Pre-Market: 04:55
Merck Market Cap : 362.74B for Nov. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 362.74B |
| November 04, 2026 | 371.19B |
| November 03, 2026 | 357.14B |
| November 02, 2026 | 366.25B |
| October 30, 2026 | 369.11B |
| October 29, 2026 | 361.24B |
| October 28, 2026 | 347.91B |
| October 27, 2026 | 350.10B |
| October 26, 2026 | 347.12B |
| October 23, 2026 | 358.62B |
| October 22, 2026 | 363.48B |
| October 21, 2026 | 370.00B |
| October 20, 2026 | 366.10B |
| October 19, 2026 | 354.57B |
| October 16, 2026 | 360.30B |
| October 15, 2026 | 358.42B |
| October 14, 2026 | 363.80B |
| October 13, 2026 | 350.50B |
| October 12, 2026 | 359.06B |
| October 09, 2026 | 359.43B |
| October 08, 2026 | 351.49B |
| October 07, 2026 | 352.50B |
| October 06, 2026 | 350.40B |
| October 05, 2026 | 344.47B |
| October 02, 2026 | 356.23B |
| Date | Value |
|---|---|
| October 01, 2026 | 355.02B |
| September 30, 2026 | 358.72B |
| September 29, 2026 | 368.52B |
| September 28, 2026 | 367.06B |
| September 25, 2026 | 367.28B |
| September 24, 2026 | 365.31B |
| September 23, 2026 | 365.56B |
| September 22, 2026 | 372.54B |
| September 21, 2026 | 369.06B |
| September 18, 2026 | 362.57B |
| September 17, 2026 | 363.26B |
| September 16, 2026 | 357.73B |
| September 15, 2026 | 354.97B |
| September 14, 2026 | 357.58B |
| September 11, 2026 | 355.31B |
| September 10, 2026 | 357.24B |
| September 09, 2026 | 364.20B |
| September 08, 2026 | 366.49B |
| September 04, 2026 | 371.11B |
| September 03, 2026 | 376.07B |
| September 02, 2026 | 374.35B |
| September 01, 2026 | 369.95B |
| August 31, 2026 | 364.77B |
| August 28, 2026 | 366.22B |
| August 27, 2026 | 369.16B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 655.51B |
| Eli Lilly & Co. | 1.284T |
| Pfizer Inc. | 170.32B |
| Bristol Myers Squibb Co. | 129.04B |
| Viatris, Inc. | 21.91B |
Market Cap Related Metrics
| PE Ratio | 150.06 |
| PS Ratio | 5.414 |
| Price to Book Value | 8.074 |
| Price to Free Cash Flow | 24.68 |
| Price | 146.94 |
| Earnings Yield | 0.67% |
| Operating PE Ratio | 29.39 |
| Normalized PE Ratio | 49.18 |